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Abstract
Lentiviral vectors are widely used in genetic modification of human and animal cells (lentiviral
transduction) to enhance their therapeutic potential by expression of recombinant protective
and trophic factors. Genetic modification of cells in vitro or ex vivo achieves the specificity of
viral transduction, as modified are just cells that have been manipulated in the laboratory. In
addition,  the  introduction of  genetically  modified  cells,  but  not  pure  virus,  helps  to  avoid
introduction of viral particles into the body of the recipient. This approach allows us to control
the expression of therapeutic genes, the immunogenicity of viral vectors and viral transduction.
To date,  different  approaches are used to improve the lentiviral  transduction (polycations,
protamine sulfate, etc.), but these methods suffer from limited efficacy or high toxicity. For the
first  time we demonstrated that  the recombinant  histone N1.3  increases  the efficiency of
lentiviral transduction by more than 2 times and has no toxic effect on target cells in a wide
range of concentrations studied.
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